Get Smart! Experts Consider These Two Factors When Choosing The Right CDMO For Developing Injectable Medicines

Singota Solutions is a U.S.-based Contract Development and Manufacturing Organization (CDMO) located in Bloomington, Indiana, specializing in formulation development and aseptic fill/finish for injectable medicines. With over 20 years of experience, Singota is the ideal partner for emerging biopharmaceutical companies seeking to develop and launch injectable therapeutics efficiently and cost-effectively.

Two key factors make Singota a standout CDMO: deep technical expertise and near-term service availability. Singota’s team includes experts in process, analytical, formulation, and method development, helping clients navigate the complex journey from drug substance to drug product. Their integrated, one-stop-shop service model includes everything from preclinical development and fill/finish manufacturing to labeling, transportation testing, and cGMP supply chain management—all within a US and Europe-based network.

What truly sets Singota apart is its agility and responsiveness. While many CDMOs offer service start dates a year out, Singota is known for accelerating timelines. They routinely accommodate projects within weeks and are often called upon to rescue or rework projects others couldn’t complete. Their state-of-the-art robotic filling technology and focus on small-batch manufacturing enable flexible, fast production, even in urgent or shifting circumstances.

Singota strikes a rare balance: small and agile enough to offer personalized service, yet large and experienced enough to meet rigorous technical and regulatory demands. Their consistent regulatory track record and commitment to quality make them a trusted partner for getting things right the first time.